PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Pardis Zarepour

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 8, 2026 · JOURNAL ARTICLE

Polypharmacy status and its related risk factors among elderly patients with dyslipidemia: Iranian multi-center osteoporosis study (IMOS) 2021.

Journal of Diabetes and Metabolic Disorders

Cross-sectional observational study with modest sample size identifying associations in a specific population; descriptive rather than explanatory, no causal inference possible, and findings need confirmation in prospective or interventional designs.

PreliminaryPardis Zarepour Mahnaz Sanjari Sahar Saeedi Moghaddam

Reported

Sample size558

Polypharmacy prevalence20.8%

95% CI for polypharmacy prevalence17.2–24.9%

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support